Global Animal Vaccines Market

Global Animal Vaccines Market Insights
The global animal vaccines market size is expected to reach USD 14,937.15 Million by 2027, from USD 9,445.45 Million in 2021, at a CAGR of 15.3% during the forecast period. (2021 – 2027).

Increased outbreaks of animal disease and an ever-increasing livestock population are the primary reasons for the wider acceptance of ruminant vaccines, particularly cattle vaccines, around the world. Meat, protein, food, milk, and other commercial products such as wool and leather are all obtained from animals. Rabies vaccines, equine influenza virus vaccines, and foot and mouth disease vaccines are the most commonly used animal vaccines, which prevent the transmission of infectious agents by mimicking naturally immune defense.
Know more about this report : https://skyquestt.com/report/animal-vaccines-market

Global Animal Vaccines Market Segmental Analysis
The global animal vaccines market is segmented Based on Type, Animal Type and Region. Based on Type it is categorized into Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines, and DNA Vaccines. Based on Animal Type it is categorized into Companion Animal, Livestock Animal, and Aquaculture. Based on region it is categorized into: North America, Europe, Asia-Pacific, South America, and MEA.

Top Players Company Profiles
• Zoetis (US)
• Merck Animal Health (US)
• Boehringer Ingelheim (Germany)
• Elanco (US)
• Ceva (US)
• Virbac (France)
• Vetoquinol (France)
• Phibro Animal Health (US)
• Hester Biosciences (India)
• HIPRA (Spain)

Recent Developments
• In June 2021, Merck Animal Health and Automazioni VX, Inc. have formed a partnership. The primary objective of this partnership was to introduce Innoject Pro, a new subcutaneous chick vaccination technology. The technology will be used in combination with Merck Animal Health’s Innovax vaccines, which are designed to protect poultry from infectious diseases.
• In June 2021, The United Kingdom has announced the start of a U.K. Animal Vaccine Manufacturing and Innovation Centre in Surrey, to speed up the development of livestock vaccines and control the spread of viral diseases such as coronavirus.
• In November 2020, the virtual launch of GUMBOHATCH’s new generation Infectious Bursal Disease immune complex immunization product for broiler chickens was announced by HIPRA Indonesia.